A validated assay for the quantitative analysis of tranexamic acid in human serum by liquid chromatography coupled with electrospray ionization mass spectrometry

Clinica Chimica Acta

Volumn 411, Issue 5-6, 2010, Pages 438-443

  Grassin Delyle, Stanislas ^a,b   Abe, Emuri ^a   Batisse, Anne ^a   Tremey, Benjamin ^b   Fischler, Marc ^b   Devillier, Philippe ^b   Alvarez, Jean Claude ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Human serum; Liquid chromatography; Mass spectrometry; Tranexamic acid

Indexed keywords

PERCHLORIC ACID; TRANEXAMIC ACID;

ACCURACY; ARTICLE; BLOOD ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MEGADOSE; ELECTROSPRAY; ELECTROSPRAY MASS SPECTROMETRY; HEART SURGERY; HUMAN; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; PH MEASUREMENT; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE;

CHROMATOGRAPHY, LIQUID; HUMANS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIME FACTORS; TRANEXAMIC ACID;

EID: 75049084993     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.01.005     Document Type: Article

References (22)

1. Hoylaerts M., Lijnen H.R., and Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 673 (1981) 75-85
2. Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 5 (1994) 537-542
3. Horrow J.C., Van Riper D.F., Strong M.D., Grunewald K.E., and Parmet J.L. The dose-response relationship of tranexamic acid. Anesthesiology 82 (1995) 383-392
4. Brown R.S., Thwaites B.K., and Mongan P.D. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesth Analg 85 (1997) 963-970
5. Mannucci P.M. Hemostatic drugs. N Engl J Med 339 (1998) 245-253
6. Fergusson D.A., Hebert P.C., Mazer C.D., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008) 2319-2331
7. Fiechtner B.K., Nuttall G.A., Johnson M.E., et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg 92 (2001) 1131-1136
8. Khuhawar M.Y., and Rind F.M.A. HPLC determination of tranexamic acid in pharmaceutical preparations and blood. Chromatographia 53 (2001) 709-711
9. Matsubayashi K., Kojima C., and Tachizawa H. Determination of tranexamic acid in human serum by high-performance liquid chromatography using selective pre-column derivatization with phenyl isothiocyanate. J Chromatogr 433 (1988) 225-234
10. Elworthy P.M., Tsementzis S.A., Westhead D., and Hitchcock E.R. Determination of plasma tranexamic acid using cation-exchange high-performance liquid chromatography with fluorescence detection. J Chromatogr 343 (1985) 109-117
11. Lacroix C., Levert P., Laine G., and Goulle J.P. Microanalysis of two antifibrinolytics (epsilon-aminocaproic acid and tranexamic acid) by liquid chromatography and fluorometry. J Chromatogr 309 (1984) 183-186
12. Puigdellivol E., Carral M.E., Moreno J., Pla-Delfina J.M., and Jane F. Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man. Int J Clin Pharmacol Ther Toxicol 23 (1985) 298-301
13. Huertas-Perez J.F., Heger M., Dekker H., Krabbe H., Lankelma J., and Ariese F. Simple, rapid, and sensitive liquid chromatography-fluorescence method for the quantification of tranexamic acid in blood. J Chromatogr A 1157 (2007) 142-150
14. Miyazaki H., Ishibashi M., Idzu G., and Izawa T. Mass fragmentographic determination of trans-4-Aminomethylcyclohexanecarboxylic acid (tranexamic acid) by use of peak matching operation. Chem Pharm Bull 23 (1975) 1806-1813
15. Eriksson O., Kjellman H., Pilbrant A., and Schannong M. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 7 (1974) 375-380
16. Lin F.M., Kou H.S., Wu S.M., Chen S.H., Kwan A.L., and Wu H.L. An ionizable chromophoric reagent for the analysis of primary amine-containing drugs by capillary electrophoresis. Electrophoresis 26 (2005) 621-626
17. Nuttall G.A., Gutierrez M.C., Dewey J.D., et al. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery. J Cardiothorac Vasc Anesth 22 (2008) 230-235
18. Chang Q., Yin O.Q., and Chow M.S. Liquid chromatography-tandem mass spectrometry method for the determination of tranexamic acid in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 805 (2004) 275-280
19. U.S. Food and Drug Administration: Centre for Drug Evaluation and Research: Guidance for Industry. Bioanalytical Method Validation., 2001, http://www.fda.gov/cder/guidance/4252fnl.pdf, accessed June 27, 2009.
20. Bourguignon B., and Massart D.L. Stationary phase degradation in reversed-phase liquid chromatography: a possible cause of bad predictions in experimental design. Anal Chim Acta 282 (1993) 33-45
21. VCCLAB, Virtual Computational Chemistry Laboratory, 2005, http://www.vcclab.org, accessed September 23, 2009.
22. Tetko I.V., Gasteiger J., Todeschini R., et al. Virtual computational chemistry laboratory-design and description. J Comput Aided Mol Des 19 (2005) 453-463